US2010152117A1PendingUtilityA1
Aequorin-Containing Compositions and Methods of Using Same
Est. expiryJun 21, 2024(expired)· nominal 20-yr term from priority
Inventors:Mark Y. Underwood
A61P 9/10A61P 39/06A61P 43/00A61P 37/04A61P 37/02A61P 5/00A61P 25/28A61P 31/12A61P 35/00A61P 3/14A61P 25/00A61P 3/00A61P 21/00A61P 19/08A61K 38/17
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions containing aequorin and methods for their use in preventing and/or alleviating symptoms and disorders related to calcium imbalance are provided by the present invention.
Claims
exact text as granted — not AI-modified1 . A composition for preventing or alleviating a symptom or disorder associated with calcium imbalance comprising:
(a) an effective amount of aequorin; and (b) an acceptable carrier.
2 . The composition according to claim 1 further comprising an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, anti-viral agent, or a mixture thereof.
3 . The composition according to claim 1 , wherein said composition is in a unit dosage form selected from the group consisting of a tablet, a capsule, a solution, a suspension, a syrup, a beverage, an oral or ophthalmic formulation and an injection.
4 . A method for preventing or alleviating a symptom or disorder associated with calcium imbalance comprising administering to a subject in need of such treatment an effective amount of aequorin.
5 . The method according to claim 4 wherein the symptom or disorder associated with calcium imbalance is related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion or bone mineralization.
6 . The method according to claim 4 wherein the symptom or disorder is caused by ischemia.
7 . The method according to claim 4 , wherein said effective amount of aequorin is provided in combination with an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, anti-viral agent, or a mixture thereof.
8 . The method according to claim 4 wherein said effective amount of aequorin is in a unit dosage form selected from the group consisting of a tablet, a capsule, a solution, a suspension, a syrup, a beverage, an oral or ophthalmic formulation and an injection.Join the waitlist — get patent alerts
Track US2010152117A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.